2022 Update COSDA Annual Conference October 2 2022 Siobhan DeLancey RVT MPH Senior Advisor for Strategic Communications wwwfdagov One Health Related Actions Issued four Warning Letters ID: 1042901
Download Presentation The PPT/PDF document "FDA Center for Veterinary Medicine" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
1. FDA Center for Veterinary Medicine 2022 UpdateCOSDA Annual ConferenceOctober 2, 2022Siobhan DeLancey, RVT, MPHSenior Advisor for Strategic Communications
2. www.fda.gov
3. One Health - Related ActionsIssued four Warning Letters for CBD products sold for use in food-producing animalsMade a low-risk determination for marketing of products from genome-edited beef cattle with “slick” hair coatsOpened docket on antimicrobial use in companion animals and relationship to development of antimicrobial resistanceCautioned pet owners and prescribers about fatalities in dogs exposed to topical chemotherapy treatmentsLaunched a resource page for human/animal food producers affected by flooding/severe weather incidents
4. www.fda.govOctober 18 FDA Virtual Listening Session:Regulation of Animal Foods with Certain Types of ClaimsDrug or Food Ingredient? Food Additive or GRAS?Includes but not limited to claims for:Environmental benefitsEffects on animal microbiomeProductionDocket open until November 17: FDA-2022-N-2015Additional meeting opportunities forthcoming: AAFCO ingredient definition process
5. Animal Drug Approvals a few highlightswww.fda.govFirst GenericsSpectoGuard: spectinomycin sulfate injectable solution for treatment of bovine respiratory diseaseTilmovet AC: tilmicosin phosphate aqueous concentrate for certain swine respiratory diseasesFirocoxib: for use in horses and dogs for osteoarthritis, for dogs for post-op pain and inflammationConditional ApprovalCanalevia-CA1: crofelemer for treatment of chemo-induced diarrhea in dogsInnovative ApprovalSolensia: frunevetmab injection, the first treatment for the control of pain associated with osteoarthritis in cats and the first monoclonal antibody (mAb) new animal drug approved by the FDA for use in any animal species.
6. www.fda.gov
7.